SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-008995
Filing Date
2024-03-07
Accepted
2024-03-07 16:01:52
Documents
1
Period of Report
2024-03-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7482
  Complete submission text file 0001127602-24-008995.txt   8930
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Issuer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016
Business Address
Dahiyat Bassil I (Reporting) CIK: 0001591312 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36182 | Film No.: 24729954